EUVIMEDEUVIMED entdecken
Crossref

Treatment Adherence and Cardiometabolic Goals in Patients with Coronary Artery Disease in the North Region of Brazil

Fernando Maia Coutinho, Talles L. Pereira Nogueira, Dilma do Socorro Moraes de Souza, Lucianna Serfaty de Holanda, Vitor Bruno Teixeira de Holanda, Michele N. Assad, Rafael M. Coutinho, Ana Flávia Oliveira de Souza, Márcio César Ribeiro Marvão, Thiago da Silva Paulo

International Journal of Cardiovascular Sciences · 08.07.2026 · 39

DOI: 10.36660/ijcs.20250291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cardiovascular Sciences, erschienen am 08.07.2026. Verfasst von Fernando Maia Coutinho und 9 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with coronary artery disease (CAD) are categorized by cardiovascular risk depending on associated risk factors and events, requiring more rigorous treatment goals.

Objective

To investigate treatment adherence, using the Morisky–Green test, and achievement of metabolic goals at a tertiary public hospital in Belém, Pará, Brazil.

Methods

This observational, cross-sectional, and analytical study was conducted with a sample of 106 patients with CAD at very high cardiovascular risk, treated in the outpatient clinic of a tertiary care hospital. The following data were collected over a 4-month period: demographic information, medication adherence (Morisky–Green test), modifiable risk factors, and laboratory parameters (lipids, blood glucose, blood pressure, heart rate, and abdominal circumference). Associations were assessed using chi-square test or G test, and correlations were analyzed using Spearman's test, adopting a significance level of 5% (p < 0.05).

Results

Treatment adherence analysis showed an adherence rate of 16.0%. Low-density lipoprotein (LDL) -cholesterol levels were above the target of 50 mg/dL in 72.6% of patients, and normal blood glucose was achieved in 75.5%. Education level was the only epidemiological variable associated with therapeutic non-adherence (p = 0.0130). Regarding financial aspects, only 9.4% reported persistent difficulty in purchasing medications; among those reporting difficulty, high-potency statins were the most frequently cited (58.6%).

Conclusions

Education level was shown to be a determining factor in understanding treatment, impacting adherence. Laboratory tests revealed significant deficiencies in lipid control, reinforcing the need for clinical optimization. Difficulties in accessing statins and low medication adherence underscore the importance of educational interventions and multidisciplinary approaches for better management of CAD.

Zitieren

APA

Coutinho, F. M., Nogueira, T. L. P., Souza, D. D. S. M. D., Holanda, L. S. D., Holanda, V. B. T. D., Assad, M. N., Coutinho, R. M., Souza, A. F. O. D., Marvão, M. C. R., & Paulo, T. D. S. (2026). Treatment Adherence and Cardiometabolic Goals in Patients with Coronary Artery Disease in the North Region of Brazil. International Journal of Cardiovascular Sciences, 39. https://doi.org/10.36660/ijcs.20250291

Vancouver

Coutinho FM, Nogueira TLP, Souza DDSMD, Holanda LSD, Holanda VBTD, Assad MN, et al. Treatment Adherence and Cardiometabolic Goals in Patients with Coronary Artery Disease in the North Region of Brazil. International Journal of Cardiovascular Sciences. 2026;39. doi:10.36660/ijcs.20250291

BibTeX
@article{Coutinho2026,
  author = {Coutinho, Fernando Maia and Nogueira, Talles L. Pereira and Souza, Dilma do Socorro Moraes de and Holanda, Lucianna Serfaty de and Holanda, Vitor Bruno Teixeira de and Assad, Michele N. and Coutinho, Rafael M. and Souza, Ana Flávia Oliveira de and Marvão, Márcio César Ribeiro and Paulo, Thiago da Silva},
  title = {Treatment Adherence and Cardiometabolic Goals in Patients with Coronary Artery Disease in the North Region of Brazil},
  journal = {International Journal of Cardiovascular Sciences},
  year = {2026},
  volume = {39},
  doi = {10.36660/ijcs.20250291}
}
Kostenlos starten →